Blog

Regulatory

Data information and disclosurePart 3 Author: Dr. Cheryl L. Rowe-Rendleman Some exciting new changes were announced in 2023 that... read more

November 30, 2023

Conducting Clinical Trials

Part 2Author: Dr. Cheryl L. Rowe-Rendleman In the United States, “biological products” are subject to a different premarket pathway... read more

October 16, 2023

Obtaining Early Regulatory Advice — INTERACT Meetings

Part 1Author: Dr. Cheryl L. Rowe-Rendleman In the United States, “biologic products” are subject to a different premarket pathway than products regulated as “drugs”. This 3-part blog series describes... read more

March 14, 2023

IN MEMORY OF A YW WOMAN ON A MISSION

Amanda DeAngelis (née Sileo) joined the YWCA Princeton in 2017 as a Communications and Marketing Manager, and was an inaugural member of the NEXT GEN Board. She was a... read more

December 14, 2022

Diabetic Eye Disease Awareness: Encourage those with diabetes to take proactive steps to protect their vision

Overview of New Drugs and Research in Diabetic Eye Disease Author: Dr. Cheryl L . Rowe-RendlemanCEO and Managing ConsultantOmar Consulting Group, LLC Diabetes is a group of diseases characterized... read more